Article Sidebar

PDF
Date Published: 13/09/2021
Abstract Views: 240
Views PDF: 171
DOI: https://doi.org/10.51298/vmj.v505i2.1130
Issue
Vol. 505 No. 2 (2021)
Section
Các bài báo
How to Cite
Thị Thu Trang, T. ., Minh Điển, T. ., Huy Tuấn Kiệt, P. ., & Xuân Hoàng, V. . (2021). DIRECT TREATMENT COST OF BRONCHOPULMONARY DYSPLASIA AT VIETNAM NATIONAL CHILDREN’S HOSPITAL IN 2020. Vietnam Medical Journal, 505(2). https://doi.org/10.51298/vmj.v505i2.1130

DIRECT TREATMENT COST OF BRONCHOPULMONARY DYSPLASIA AT VIETNAM NATIONAL CHILDREN’S HOSPITAL IN 2020

Trần Thị Thu Trang1,, Trần Minh Điển1, Phạm Huy Tuấn Kiệt2, Vũ Xuân Hoàng3
1 Vietnam National Children's Hospital
2 Hanoi Medical University
3 The Planning and Finance Department, Ministry of Health

Main Article Content

Abstract

Objectives: To describe direct medical cost and related factors for treatment of bronchopulmonary dysplasia (BPD) at the Vietnam National Children's Hospital in 2020. Methodology: Cross-sectional study, quantitative analysis on medical and financial records of all premature infants with bronchopulmonary dysplasia, treated at the National Children's Hospital in 2020. Findings: Among 116 premature infants with bronchopulmonary dysplasia, males in majority with 63,8%, premature < 28 weeks with 59,8%. The average annual total direct medical cost per infant was 3292.5 ± 3043.8 USD. Value of cost is proportional to birth weight and length of stay. Conclusion: Cost in Vietnam is significantly comparing with similar international studies. Policy of free health insurance for children < 6 year olds and co-payment of < 20% reduced the financial burden of families having premature infant with bronchopulmonary dysplasia largely. It was totally affordable in Vietnam.

Article Details

Keywords

Cost, bronchopulmonary dysplasia, infants, Vietnam National Children’s Hospital

References

1. World Health Organization (2018). Preterm birth., accessed: 01/01/2021.
2. Jensen E.A. và Schmidt B. (2014). Epidemiology of bronchopulmonary dysplasia.Birt Defects Res A Clin Mol Teratol, 100(3), 145–157.
3. Baker C.D. và Alvira C.M. (2014). Disrupted lung development and bronchopulmonary dysplasia: opportunities for lung repair and regeneration. Curr Opin Pediatr, 26(3), 306–314.
4. Smith V.C., Zupancic J.A.F., McCormick M.C. và cộng sự. (2004). Rehospitalization in the first year of life among infants with bronchopulmonary dysplasia.J Pediatr, 144(6), 799–803.
5. Lapcharoensap W., Bennett M.V., Xu X. và cộng sự. (2020). Hospitalization costs associated with bronchopulmonary dysplasia in the first year of life. J Perinatol Off J Calif Perinat Assoc, 40(1), 130–137.
6. Álvarez-Fuente M., Arruza L., Muro M. và cộng sự. (2017). The economic impact of prematurity and bronchopulmonary dysplasia. Eur J Pediatr, 176(12), 1587–1593.
7. Landry J.S., Croitoru D., Jin Y. và cộng sự.(2012). Health care utilization by preterm infants with respiratory complications in Quebec.Can Respir J, 19(4), 255–260.
8. Merritt T.A., Pillers D., và Prows S.L. (2003). Early NICU discharge of very low birth weight infants: a critical review and analysis. Semin Neonatol SN, 8(2), 95–115.